Faezeh Sheakri

Dr. Faezeh Sheakri

Royan Institute, Tehran, Tehrān, Iran
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
CTClotilde Théry
Clotilde Théry
KWKenneth Witwer
Kenneth Witwer
EAElena Aikawa
Elena Aikawa
MAMaria Jose Alcaraz
Maria Jose Alcaraz
JAJohnathon Anderson
Johnathon Anderson
Ewa Zuba-SurmaEwa Zuba-Surma
Ewa Zuba-Surma
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell‐released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV‐associated functional activities. Finally, a checklist is provided with summaries of key points.

7 February 2024 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
Joshua WelshJoshua Welsh
Joshua Welsh
DGDeborah Goberdhan
Deborah Goberdhan
LOLorraine O'Driscoll
Lorraine O'Driscoll
EBEdit Buzas
Edit Buzas
CBCherie Blenkiron
Cherie Blenkiron
KWKenneth Witwer
Kenneth Witwer
Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year‐on‐year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non‐vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its ‘Minimal Information for Studies of Extracellular Vesicles’, which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly.

1 September 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
FMFatemeh Mehryab
Fatemeh Mehryab
SRShahram Rabbani
Shahram Rabbani
SSSoraya Shahhosseini
Soraya Shahhosseini
FSFaezeh Sheakri
Faezeh Sheakri
Yousef FatahiYousef Fatahi
Yousef Fatahi
AHAzadeh Haeri
Azadeh Haeri

17 September 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SMSoura Mardpour
Soura Mardpour
MGMohammad Hossein Ghanian
Mohammad Hossein Ghanian
HSHamid Sadeghi-Abandansari
Hamid Sadeghi-Abandansari
SMSaeid Mardpour
Saeid Mardpour
ANAbdoreza Nazari
Abdoreza Nazari
HBHossein Baharvand
Hossein Baharvand

4 September 2020 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
Carolina SoekmadjiCarolina Soekmadji
Carolina Soekmadji
BLBo Li
Bo Li
YHYiyao Huang
Yiyao Huang
HWHaifang Wang
Haifang Wang
TATaixue An
Taixue An
LZLei Zheng
Lei Zheng
The utilization of extracellular vesicles (EVs) in clinical theranostics has rapidly advanced in the past decade. In November 2018, the International Society for Extracellular Vesicles (ISEV) held a workshop on “EVs in Clinical Theranostic”. Here, we report the conclusions of roundtable discussions on the current advancement in the analysis technologies and we provide some guidelines to researchers in the field to consider the use of EVs in clinical application. The main challenges and the requirements for EV separation and characterization strategies, quality control and clinical investigation were discussed to promote the application of EVs in future clinical studies.

16 October 2023 in Journal of Extracellular Biology
Verified
Journal Article
Open access
FSFaezeh Sheakri
Faezeh Sheakri
FAFaisal J. Alibhai
Faisal J. Alibhai
HBHossein Baharvand
Hossein Baharvand
VBVerena Börger
Verena Börger
SBStefania Bruno
Stefania Bruno
RNRienk Nieuwland
Rienk Nieuwland
Cell culture‐conditioned medium (CCM) is a valuable source of extracellular vesicles (EVs) for basic scientific, therapeutic and diagnostic applications. Cell culturing parameters affect the biochemical composition, release and possibly the function of CCM‐derived EVs (CCM‐EV). The CCM‐EV task force of the Rigor and Standardization Subcommittee of the International Society for Extracellular Vesicles aims to identify relevant cell culturing parameters, describe their effects based on current knowledge, recommend reporting parameters and identify outstanding questions. While some recommendations are valid for all cell types, cell‐specific recommendations may need to be established for non‐mammalian sources, such as bacteria, yeast and plant cells. Current progress towards these goals is summarized in this perspective paper, along with a checklist to facilitate transparent reporting of cell culturing parameters to improve the reproducibility of CCM‐EV research.